Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis



Rating:

Share or cite this content

Citations should be made in the following way:
N. Demyanenko (Moskow, Russian Federation), A. Mihail (Moskow, Russian Federation), N. Makaryants (Moskow, Russian Federation), E. Vladimirova (Moskow, Russian Federation), A. Egorova (Moskow, Russian Federation), A. Akhmedova (Moskow, Russian Federation). The role of nonspecific inflammation factors – SA-A and pentraxin-3 in patients with respiratory sarcoidosis in different age groups. 701

Member's Comments

No comment yet.

Related content which might interest you: Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 The role of systemic markers of inflammation in bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 The role of neutrophilic inflammation in asthma of different severity Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002 The relationship between comorbidities and systemic inflammation in patients with COPD Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Differences in serum levels of inflammatory markers, proteases and antiproteases in COPD patients with and without emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Are there gender differences of systemic inflammatory state in COPD patients? Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Different pattern of systemic and local inflammation in patients with exacerbation of COPD with different body composition Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 PP301 – The role of the systemic inflammation in bronchiectasis exacerbation frequency Source: ERS Lung Science Conference 2021 Year: 2021 Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Systemic inflammation in exacerbated patients with chronic obstructive pulmonary disease (COPD): the role of alterations in leptin/ghrelin ratio and/or leptin/adiponectin ratio Source: Annual Congress 2007 - Biomarkers and assessment of COPD Year: 2007 Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD) Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007 Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003 The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012